Intraindividual comparison of myocardial delayed enhancement MR imaging using gadobenate dimeglumine at 1.5 T and 3 T

European Radiology

Volumn 19, Issue 5, 2009, Pages 1124-1131

  Klumpp, Bernhard D ^a   Sandstede, Joern ^b   Lodemann, Klaus P ^c   Seeger, Achim ^a   Hoevelborn, Tobias ^a   Fenchel, Michael ^a   Kramer, Ulrich ^a   Claussen, Claus D ^a   Miller, Stephan ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Roentgenzentrum Schaeferkampsallee   (Germany)

^c Bracco Altana Pharma   (Germany)

Author keywords

3 T; Contrast media; High field MR imaging; Myocardial infarction; Myocardial viability

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGNAL NOISE RATIO;

ADULT; AGED; BODY WEIGHT; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; MODELS, STATISTICAL; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS; VENTRICULAR FUNCTION, LEFT;

EID: 64249122505     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-1248-7     Document Type: Article

References (30)

1. Huber A, Bauner K, Wintersberger BJ et al (2006) Phase-sensitive inversion recovery (PSIR) single-shot TrueFISP for assessment of myocardial infarction at 3 tesla. Invest Radiol 41:148-153
2. Gutberlet M, Noeske R, Schwinge K et al (2006) Comprehensive cardiac magnetic resonance imaging at 3.0 tesla: Feasibility and implications for clinical applications. Invest Radiol 41:154-167
3. Rinck PA, Muller RN (1999) Field strength and dose dependence of contrast enhancement by gadolinium-based MR contrast agents. Eur Radiol 9:998-1004
4. Schar M, Kozerke S, Fischer SE et al (2004) Cardiac SSFP imaging at 3 tesla. Magn Reson Med. 51:799-806
5. Larsson EM, Stahlberg F (2005) 3 tesla magnetic resonance imaging of the brain. Better morphological and functional images with higher magnetic field strength. Lakartidningen 102:460-463
6. Thulborn KR (2000) Clinical rationale for very-high-field (3.0 tesla) functional magnetic resonance imaging. Top Magn Reson Imaging 1999; 10:37-50
7. Robitaille PM, Abduljalil AM, Kangarlu A. Ultra high resolution imaging of the human head at 8 tesla: 2K × 2K for Y2K. J Comput Assist Tomogr 24:2-8
8. Greenman RL, Shirosky JE, Mulkern RV et al (2003) Double inversion black-blood fast spin-echo imaging of the human heart: A comparison between 1.5 T and 3.0 T. J Magn Reson Imaging 17:648-655
9. Pintaske J, Martirosian P, Graf H et al (2006) Relaxivity of gadopentate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5 and 3 tesla. Invest Radiol 41:213-221
10. Kim RJ, Fieno DS, Parrish TB et al (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 19:1992-2002
11. Ansari M, Araoz PA, Gerard SK et al (2004) Comparison of late enhancement cardiovascular magnetic resonance and thallium SPECT in patients with coronary disease and left ventricular dysfunction. J Cardiovasc Magn Reson 6:549-556
12. Sakuma H (2002) Optimal use of contrast medium in contrast enhanced MR imaging of the heart. Nippon Igaku Hoshasen Gakkai Zasshi 62:682-689
13. Hunold P, Brandt-Mainz K, Freudenberg L et al (2002) Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging - comparison of late enhancement technique with positron emission tomography. Fortschr Rontgenstr 174:867-873
14. Kim RJ, Shah DJ (2004) Fundamental concepts in myocardial viability assessment revisited: When knowing how much is "alive" is not enough. Heart 90:137-140
15. Mahrholdt H, Wagner A, Parker M et al (2003) Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease. J Am Coll Cardiol 42:505-512
16. Cameron AA, Davis KB, Rogers WJ (1995) Recurrence of angina after coronary artery bypass surgery: Predictors and prognosis (CASS Registry). Coronary Artery Surgery Study. J Am Coll Cardiol 26:895-899
17. Van Dijkman PR, Hold KM, van der Laarse A et al (1993) Sequential analysis of infarcted and normal myocardium in piglets using in vivo gadolinium-enhanced MR images. Magn Reson Imaging 11:207-218
18. Fieno DS, Kim RJ, Chen EL et al (2000) Contrast enhanced magnetic resonance imaging of myocardium at risk: Distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 36:1985-1991
19. Depre C, Vanoverschelde JL, Melin JA et al (1995) Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 268:1265-1275
20. Kim RJ, Wu E, Rafael A et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445
21. Klumpp B, Fenchel M, Hoevelborn T et al (2006) Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 tesla. Invest Radiol 41:661-667
22. Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539-542
23. Gutberlet M, Schwinge K, Freyhardt P et al (2005) Influence of high magnetic field strengths and parallel acquisition strategies on image quality in cardiac 2D CINE magnetic resonance imaging: Comparison of 1.5 T vs 3.0 T. Eur Radiol 15:1586-1597
24. Juergens KU, Wichter T, Renger B et al (2001) MRI study of left ventricular function in patients with coronary disease and myocardial dysfunction before and after coronary revascularization. Fortschr Rontgenstr 173:211-217
25. Kloner RA, Przyklenk K (1991) Hibernation and stunning of the myocardium. N Engl J Med 325:1877-1879
26. Lima JA, Judd RM, Bazille A et al (1995) Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 92:1117-1125
27. Kloner RA, Ganote CE, Jennings RB (1974) The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54:1496-1508
28. Wu KC, Zerhouni EA, Judd RM et al (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97:765-772
29. Helak JW, Reichek N (1981) Quantitation of left ventricular mass and volume by two-dimensional echocardiography: In vitro anatomic validation. Circulation 63:1398-1407
30. Weyman AE (1994) Principles and practice of echocardiography. Lea & Febriger, Philadelphia, p 1335 p 1335